Gastroenteropancreatic Neuroendocrine Neoplasm
📧 Sign up to get email alerts when something new happens for Gastroenteropancreatic Neuroendocrine Neoplasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1) [Phase 1]
Phase 1 first-in-human study of ML261, an autologous DLL3-targeted CAR T cell therapy, in relapsed/refractory small cell lung cancer and sel…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas [Phase 1]
Phase 1 clinical trial update for NP-101 (TQ Formula) in combination with nivolumab and ipilimumab for advanced or metastatic extra-pulmonar…